-
1
-
-
0025329374
-
The emergence of bacterial resistance in hospitals: A need for continuous surveillance
-
Brown EH, Spencer RC, Brown JMC. The emergence of bacterial resistance in hospitals: A need for continuous surveillance. J Hosp Infect 1990; 125 (suppl A): 35-9.
-
(1990)
J Hosp Infect
, vol.125
, Issue.SUPPL. A
, pp. 35-39
-
-
Brown, E.H.1
Spencer, R.C.2
Brown, J.M.C.3
-
2
-
-
25544461564
-
Trends in antimicrobial utilization and bacterial resistance: Report of the National Resistance Surveillance Group
-
Ballow CH, Schentag JJ. Trends in antimicrobial utilization and bacterial resistance: Report of the National Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992; 15 (suppl): 37S-42S.
-
(1992)
Diagn Microbiol Infect Dis
, vol.15
, Issue.SUPPL.
-
-
Ballow, C.H.1
Schentag, J.J.2
-
3
-
-
0028054242
-
Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. Study on the threat of emerging resistances: Real or perceived?
-
Jones RN, Kehrberg EN, Erwin ME, Anderson SC, and the Fluoroquinolone Resistance Surveillance Group. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. Study on the threat of emerging resistances: Real or perceived? Diagn Microbiol Infect Dis 1994; 19: 203-15.
-
(1994)
Diagn Microbiol Infect Dis
, vol.19
, pp. 203-215
-
-
Jones, R.N.1
Kehrberg, E.N.2
Erwin, M.E.3
Anderson, S.C.4
-
4
-
-
0028883511
-
β-lactamases in laboratory and clinical resistance
-
Livermore DM. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
-
(1995)
Clin Microbiol Rev
, vol.8
, pp. 557-584
-
-
Livermore, D.M.1
-
5
-
-
0030180076
-
Survey of extended β-lactamases among Enterobacteriaceae
-
Chanal C, Sirot D, Romaszko JP, Bret L, Sirot J. Survey of extended β-lactamases among Enterobacteriaceae. J Antimicrob Chemother 1996; 38: 127-32.
-
(1996)
J Antimicrob Chemother
, vol.38
, pp. 127-132
-
-
Chanal, C.1
Sirot, D.2
Romaszko, J.P.3
Bret, L.4
Sirot, J.5
-
7
-
-
0021335528
-
Inducible β-lactamase and non-hydrolytic resistance mechanisms
-
Sanders CC. Inducible β-lactamase and non-hydrolytic resistance mechanisms. J Antimicrob Chemother 1984; 13: 1-3.
-
(1984)
J Antimicrob Chemother
, vol.13
, pp. 1-3
-
-
Sanders, C.C.1
-
8
-
-
0024042861
-
Clinical and epidemiological implications for use of newer cephalosporins
-
Sanders CC, Sanders WE Jr. Clinical and epidemiological implications for use of newer cephalosporins. Rev Infect Dis 1988; 10: 830-6.
-
(1988)
Rev Infect Dis
, vol.10
, pp. 830-836
-
-
Sanders, C.C.1
Sanders Jr., W.E.2
|